Consultant in Haemato-Oncology


MBChB, BSc Hons, FRCP, FRCPath, Dip PGME

GMC number:



Dr Breaton specialises in the care of people with myeloma and plasma cell disorders.

She is keen to develop knowledge around the optimal care and treatments for people with myeloma and related conditions such as AL amyloidosis. She has developed specialist clinical services to help investigate people who may have amyloid or kidney damage related to specific blood abnormalities.  

Dr Brearton is involved in clinical trials as an investigator for new treatments in myeloma.

She is interested in creating effective learning opportunities for junior colleagues and is the haematology lead for education.